5.22
price down icon1.51%   -0.08
 
loading
Precedente Chiudi:
$5.30
Aprire:
$5.29
Volume 24 ore:
59,644
Relative Volume:
1.50
Capitalizzazione di mercato:
$31.22M
Reddito:
$147.75M
Utile/perdita netta:
$-284.23M
Rapporto P/E:
-1.7816
EPS:
-2.93
Flusso di cassa netto:
$-317.54M
1 W Prestazione:
-9.22%
1M Prestazione:
-35.05%
6M Prestazione:
-64.00%
1 anno Prestazione:
-79.73%
Intervallo 1D:
Value
$5.18
$5.4617
Intervallo di 1 settimana:
Value
$5.18
$5.8467
Portata 52W:
Value
$4.50
$38.25

Fibrogen Inc Stock (FGEN) Company Profile

Name
Nome
Fibrogen Inc
Name
Telefono
415-978-1200
Name
Indirizzo
350 BAY STREET, SAN FRANCISCO, CA
Name
Dipendente
225
Name
Cinguettio
@FibroGenInc
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
FGEN's Discussions on Twitter

Confronta FGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FGEN
Fibrogen Inc
5.22 31.22M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-08-08 Downgrade BofA Securities Neutral → Underperform
2023-06-26 Downgrade BofA Securities Buy → Neutral
2023-06-26 Downgrade Raymond James Outperform → Mkt Perform
2023-06-26 Downgrade Stifel Buy → Hold
2023-06-26 Downgrade William Blair Outperform → Mkt Perform
2023-06-02 Aggiornamento Stifel Hold → Buy
2023-01-31 Aggiornamento William Blair Mkt Perform → Outperform
2023-01-26 Aggiornamento Raymond James Mkt Perform → Outperform
2023-01-05 Aggiornamento BofA Securities Neutral → Buy
2021-09-22 Downgrade Goldman Neutral → Sell
2021-08-20 Aggiornamento Raymond James Underperform → Mkt Perform
2021-07-16 Downgrade BofA Securities Buy → Neutral
2021-07-16 Downgrade Stifel Buy → Hold
2021-04-07 Downgrade H.C. Wainwright Buy → Neutral
2021-04-07 Downgrade Mizuho Buy → Neutral
2021-03-31 Aggiornamento BofA Securities Neutral → Buy
2021-03-02 Downgrade Jefferies Buy → Hold
2021-02-01 Iniziato H.C. Wainwright Buy
2020-10-26 Iniziato Raymond James Underperform
2020-07-10 Ripresa Stifel Buy
2020-05-01 Iniziato Cowen Market Perform
2020-04-27 Iniziato BofA/Merrill Neutral
2019-05-29 Ripresa Goldman Neutral
2019-05-10 Downgrade William Blair Outperform → Mkt Perform
2019-04-12 Iniziato Piper Jaffray Neutral
2019-02-11 Ripresa Stifel Buy
2018-12-19 Aggiornamento Citigroup Neutral → Buy
2017-08-08 Reiterato Leerink Partners Outperform
2017-08-08 Reiterato Stifel Buy
2017-07-21 Downgrade Goldman Buy → Neutral
2017-07-11 Iniziato Jefferies Buy
2016-02-11 Aggiornamento Credit Suisse Neutral → Outperform
2016-01-21 Iniziato Credit Suisse Neutral
2015-12-04 Iniziato Citigroup Buy
2015-09-23 Iniziato Lake Street Hold
2015-07-29 Iniziato Citigroup Buy
2015-07-20 Aggiornamento Goldman Neutral → Buy
2014-12-09 Iniziato Stifel Buy
Mostra tutto

Fibrogen Inc Borsa (FGEN) Ultime notizie

pulisher
Jun 16, 2025

FibroGen (FGEN) Trading Halted Pending News Release | FGEN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 13, 2025

FibroGen Enters New Agreement with HiFiBiO - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Fibrogen IncOn June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split | FGEN St - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen to implement 1-for-25 reverse stock split; shares down 15% - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Adobe, RH And 3 Stocks To Watch Heading Into FridayAdobe (NASDAQ:ADBE), FibroGen (NASDAQ:FGEN) - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces 1-for-25 Reverse Stock Split | FGEN Stock New - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces Reverse Stock Split Effective June 16 - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen to Implement 1-for-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen To Implement 1-for-25 Reverse Stock Split - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025 - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Fibrogen Announces 1-For-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces 1-for-25 Reverse Stock Split - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen's Massive 1-for-25 Reverse Split Cuts 101M Shares to 4MWhat Investors Must Know - Stock Titan

Jun 12, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Lowers Stock Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Amends Financing Agreement for Flexibility - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors | FGEN Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Fibrogen Appoints Michael Kauffman To Its Board Of Directors - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Takes Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Has $465,000 Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 05, 2025
pulisher
May 19, 2025

FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 17, 2025

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline - MSN

May 17, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

FibroGen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Negative Outlook for FibroGen Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

FibroGen’s Earnings Call: Strategic Gains Amid Revenue Woes - TipRanks

May 15, 2025
pulisher
May 15, 2025

FibroGen (NASDAQ:FGEN) Earns Buy Rating from HC Wainwright - Defense World

May 15, 2025
pulisher
May 14, 2025

FibroGen (FGEN) Boosts Sale Proceeds from Chinese Division - GuruFocus

May 14, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwrigh - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc earnings beat by $0.15, revenue fell short of estimates - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid Revenue Decline - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Reports Q1 2025 Earnings and Strategic Updates - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: FibroGen Q1 2025 sees revenue drop, stock rises - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

FibroGen Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $2.7M, EPS Misses with $0.16 Loss - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimat - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
pulisher
May 12, 2025

FIBROGEN INC SEC 10-Q Report - TradingView

May 12, 2025

Fibrogen Inc Azioni (FGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Fibrogen Inc Azioni (FGEN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):